Instil Bio, Inc. Common Stock (TIL)
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Instil Bio, Inc. Common Stock (TIL) is listed on Nasdaq, where it has traded since March 19, 2021.
- Listed On
- Nasdaq
- Listed Since
- March 19, 2021
- Employees
- 17
- Market Cap
- $49M
About Instil Bio, Inc. Common Stock
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 24 institutions reported holding TIL, with 3.8 million shares worth $29.2 million in aggregate. The largest reported holder was Curative Ventures V, with 1.9 million shares worth $14.6 million. Of the 5 largest holders listed below, 1 added shares, 1 reduced its position and 3 held their positions unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Curative Ventures V | 1,899,004 | $15M | Unchanged |
| Bml Capital Management | 645,600 | $5M | Unchanged |
| Vivo Capital | 292,743 | $2M | Unchanged |
| Vanguard | 187,981 | $1M | Reduced 5.38% |
| UBS Group | 177,423 | $1M | Added 2681.8% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is TIL?
Instil Bio, Inc. Common Stock (TIL) is listed on Nasdaq, where it has traded since March 19, 2021.
Who are the largest institutional holders of TIL?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of TIL were Curative Ventures V, Bml Capital Management and Vivo Capital.
How many institutions own TIL?
24 institutions reported a position in TIL for the quarter ended June 30, 2026, worth $29.2 million in total.
Did institutions buy or sell TIL last quarter?
Of the 5 largest reported holders, 1 added shares, 1 reduced its position and 3 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for TIL.
Every reported institutional holder, plus insider and congressional trades in TIL, on SentiSense.